JSC STADA SUBSIDIARY

Company Introduction:

JSC STADA SUBSIDIARY in Uzbekistan is an integral part of STADA Arzneimittel AG, a prominent global pharmaceutical company headquartered in Germany. The Uzbek subsidiary is dedicated to the production, marketing, and distribution of a diverse portfolio of pharmaceutical products. Its offerings typically encompass generic drugs, over-the-counter (OTC) medications, and specialty pharmaceuticals, aimed at addressing the healthcare demands of the Uzbek population and potentially extending to other Central Asian markets. The company benefits from STADA's extensive global experience in pharmaceutical research, development, stringent quality control, and effective marketing strategies, ensuring the provision of high-quality and accessible medicines to patients. Its operational footprint in Uzbekistan has been significantly bolstered through strategic acquisitions, integrating local manufacturing capabilities into STADA's broader international network.

Factory or Trader:

JSC STADA SUBSIDIARY is primarily a PHARMACEUTICAL MANUFACTURER. It operates production facilities within Uzbekistan. Concurrently, as a manufacturer of pharmaceutical products, it also actively engages in the TRADING and distribution of these medicines. Therefore, it functions as both a manufacturer and a trader within the pharmaceutical supply chain.

JSC STADA SUBSIDIARY in Uzbekistan manufactures and sells a broad portfolio of pharmaceutical products. These products primarily fall into three strategic segments:

1. Generics: A wide range of high-quality generic medicines covering various therapeutic areas, including but not limited to:

* Cardiovascular diseases

* Central nervous system disorders

* Gastrointestinal conditions

* Pain management

* Anti-infectives

* Metabolic disorders

2. Consumer Healthcare (Over-the-Counter - OTC) Products: Non-prescription medicines and health products for common ailments and daily wellness, such as:

* Cold and flu remedies

* Pain relievers

* Vitamins and supplements

* Dermatological preparations

* Nasal decongestants

3. Specialty Pharmaceuticals: Medicines for specific and often more complex conditions, which may include products in areas like:

* Oncology

* Immunology

* Rare diseases

Following STADA's acquisition of Takeda Pharmaceutical Company's portfolio in Russia and CIS countries, the Uzbekistan subsidiary also distributes a significant number of products previously marketed by Takeda, further expanding its offerings in areas such as gastroenterology and neurology.